Significant differences were found among these 3 therapy groups with respect to median tumor size, BCLC stage, baseline HBV DNA levels, and AFP levels, whereas nonsignificant differences were found in Child-Pugh scores, albumin levels, and Impact-R platelet counts. This evidence concerns the gene AFP and neoplasm.